Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
FLAC was delisted on the 22nd of November, 2022.
49 hedge funds and large institutions have $93.7M invested in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
19% more capital invested
Capital invested by funds: $78.9M → $93.7M (+$14.8M)
2% more funds holding
Funds holding: 48 → 49 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$5.11M |
| 2 |
D.E. Shaw & Co
New York
|
+$1.94M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$1.47M |
| 4 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$1.47M |
| 5 |
CCM
Context Capital Management
Lajolla,
California
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$858K |
| 2 |
BCM
Bluefin Capital Management
New York
|
-$694K |
| 3 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$624K |
| 4 |
DFCM
Dark Forest Capital Management
San Juan,
Puerto Rico
|
-$175K |
| 5 |
Millennium Management
New York
|
-$149K |
FLAC Hedge Fund Activity: Q1 2022 in Review
49 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) for Q1 2022, worth a combined $93.7M — up 19% from $78.9M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FLAC positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 5 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $5.11M. The largest seller was Beryl Capital Management, exiting entirely with an estimated $858K sold.
- 49 institutional investors held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) as of Q1 2022, up from 48 in Q4 2021.
- Funds reported $93.7M of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares stock for Q1 2022, up 19% quarter-over-quarter.
- 6 funds opened new Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares positions in Q1 2022 and 5 closed out, a net change of +1 holder.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares buyer in Q1 2022 was Goldman Sachs, an estimated $5.11M added.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares seller in Q1 2022 was Beryl Capital Management, an estimated $858K sold.
Based on aggregated 13F filings for Q1 2022.